Literature DB >> 671607

Studies in inhibitors of calcification and levels of urine saturation with calcium salts in recurrent stone patients.

P O Crassweller, D G Oreopoulos, A Toguri, H Husdan, D R Wilson, A Rapoport.   

Abstract

Studies have been done on patients with recurrent renal calculous disease, measuring in addition to the usual serum and urine constituents the inhibiting capacity of the urine and the activity products of calcium oxalate, octocalcium phosphate and brushite. Studies on the 24-hour urine calcium, phosphorus and uric acid and serum calcium indicate no essential differences between patients with calcium oxalate, mixed or uric acid stones and normal individuals. We were unable to demonstrate a difference in the inhibiting capacity of the urine between normal individuals and patients with calcium oxalate calculi, and levels of saturation of urine with calcium oxalate were identical in the calcium oxalate stone patients and normal individuals. The degree of saturation of urine with calcium phosphate is significantly greater in stone patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 671607     DOI: 10.1016/s0022-5347(17)57021-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

Review 1.  Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 2.  The scientific basis of calcium oxalate urolithiasis. Predilection and precipitation, promotion and proscription.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.